D
Monopar Therapeutics Inc. MNPR
$80.13 -$2.43-2.94% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 6.53% 75.97% -737.66% 23.96% -4.51%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -5.57% -71.95% 2,326.37% -40.46% 1.73%
Change in Net Operating Assets 102.20% -207.25% 12,822.08% 110.71% 13.71%
Cash from Operations 80.98% -183.39% -86.16% 35.98% -1.29%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 464.43% 97.73% -1,554.64% 41,170.83% 99.76%
Cash from Investing 464.43% 97.73% -1,554.64% 41,170.83% 99.76%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -69.48% -99.97% -- -100.00% -100.00%
Repurchase of Common Stock -145.31% -95.96% -305.45% -65.00% 6.54%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -173.81% -100.21% 340,323.03% -66.67% -100.31%
Foreign Exchange rate Adjustments -2,500.00% 97.37% -184.44% 200.00% 188.24%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 96.57% -115.34% 39,975.95% 94.09% -411.65%